Literature DB >> 2057435

Acute rhabdomyolysis associated with atypical Guillain-Barré syndrome.

A J Scott1, R Duncan, L Henderson, G A Jamal, P G Kennedy.   

Abstract

We report a patient with atypical Guillain-Barré syndrome associated with acute rhabdomyolysis. Rhabdomyolysis may be the cause of elevation of creatine kinase sometimes seen in patients with Guillain-Barré syndrome.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2057435      PMCID： PMC2398930          DOI： 10.1136/pgmj.67.783.73

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  4 in total

1.  Proximal versus distal slowing of motor nerve conduction velocity in the Guillain-Barré syndrome.

Authors:  J Kimura
Journal:  Ann Neurol       Date:  1978-04       Impact factor: 10.422

2.  Membranous glomerulonephritis and Landry-Guillain-Barre syndrome.

Authors:  B F Murphy; M F Gonzales; P Ebeling; K F Fairley; P Kincaid-Smith
Journal:  Am J Kidney Dis       Date:  1986-10       Impact factor: 8.860

3.  Pain in Guillain-Barré syndrome.

Authors:  A H Ropper; B T Shahani
Journal:  Arch Neurol       Date:  1984-05

4.  Unusual clinical variants and signs in Guillain-Barré syndrome.

Authors:  A H Ropper
Journal:  Arch Neurol       Date:  1986-11
  4 in total
  4 in total

1.  Rhabdomyolysis with acute renal failure triggered by the seasonal flu vaccination in a patient taking simvastatin.

Authors:  S V Shah; K Reddy
Journal:  BMJ Case Rep       Date:  2010-10-04

2.  Chronic Inflammatory Demyelinating Polyneuropathy Variant with Creatine-Kinase Elevation and Vanishing Effect of Immunoglobulins.

Authors:  Josef Finsterer; Rahim Aliyev
Journal:  Am J Case Rep       Date:  2017-07-27

3.  Guillain-Barre syndrome complicated by acute fatal rhabdomyolysis.

Authors:  Amrish Saxena; Vineeta Singh; Nitin Verma
Journal:  Indian J Crit Care Med       Date:  2014-04

4.  Clinical features of Guillain-Barré syndrome patients with elevated serum creatine kinase levels.

Authors:  Takafumi Hosokawa; Hideto Nakajima; Taiki Sawai; Yoshitsugu Nakamura; Eri Sano; Akihiro Tsukahara; Kiichi Unoda; Shimon Ishida; Sadaki Sakane; Fumiharu Kimura; Shigeki Arawaka
Journal:  BMC Neurol       Date:  2020-05-27       Impact factor: 2.474
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.